Prevalence of Oral Findings in Chronic Kidney Disease

Sponsor
Alaa Mostafa Hassan Elnaggar (Other)
Overall Status
Unknown status
CT.gov ID
NCT03074188
Collaborator
Cairo University (Other)
225

Study Details

Study Description

Brief Summary

There are severe deficiency of database concerning the oral health status in both pre-dialysis and end stage renal disease in Egyptian population. Our aim in the present study is to assess the oral health of the chronic kidney disease patients to increase their awareness and minimize all the possible risk factors, to achieve a proper management for all oral problems.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    The study will be held in the Nephrology units at the Kasr Al-Ainy Cairo university hospital. The data collected through the questionnaire will be obtained through an interview between the investigator and the patient. Clinical examination will be performed for both oral (soft tissue) and dental (hard) tissue. For patients undergoing dialysis, examination will be performed before dialysis therapy.

    Selection bias: will be minimized by enrolling the participants in the study in a consecutive order of the entering the clinic.

    Non-respondent bias: will be minimized by explaining to the participants the aim of the study and their importance and role in the study.

    Incomplete records: will be excluded from statistical analysis with reporting the cause of not completing the record.

    Sample size estimation:

    Using a precision of 5, a design effect set at 1 with 90% CI (confidence interval), a total sample size of 250 pre-dialysis patients and 200 end stage renal disease patients will be sufficient. The sample size was calculated by Epi info software.

    The sample will be divided between two researchers; each researcher will have 50% of the whole sample to collect.

    Study Design

    Study Type:
    Observational [Patient Registry]
    Anticipated Enrollment :
    225 participants
    Observational Model:
    Ecologic or Community
    Time Perspective:
    Cross-Sectional
    Official Title:
    Prevalence of Oral Findings in Adult Patients With Chronic Kidney Disease "Cross Sectional
    Anticipated Primary Completion Date :
    May 30, 2018

    Arms and Interventions

    Arm Intervention/Treatment
    pre-dialysis patients

    end stage renal disease

    Outcome Measures

    Primary Outcome Measures

    1. oral mucosal lesion [10 minutes]

      Clinical examination according to WHO guidelines

    Secondary Outcome Measures

    1. .Periodontal condition [10 minutes]

      Basic periodontal examination

    2. Hepatitis C Virus at dialysis stage [5 minutes]

      HCV antibodies in patient blood

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Inclusion Criteria:
    1. Adult patients >18 years old with a diagnosis of non-dialysis chronic kidney disease at stage 2, 3 and 4.

    2. Adult patients >18 years old with a diagnosis of end stage renal disease "stage 5".

    3. Recorded data of Glomerular Filtration Rate for every patient.

    4. Recorded data for dialysis patients (HCV, platelets count, creatinine, blood urea nitrogen, urea level and partial thromboplastin time).

    Exclusion Criteria:
    1. Adult patients <18 years.

    2. End stage renal disease undergoing peritoneal dialysis.

    3. Patients not physically able to participate in oral examination.

    4. Patients with kidney transplantation.

    5. Patients undergoing renal dialysis for reasons other than chronic kidney disease, such as acute renal failure, accidents, trauma, snake poisoning.

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • Alaa Mostafa Hassan Elnaggar
    • Cairo University

    Investigators

    • Study Chair: Mariam fakhr, the Nephrology units at the Kasr Al-Ainy Cairo university hospital.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Alaa Mostafa Hassan Elnaggar, internal resident at oral medicine department, Cairo University
    ClinicalTrials.gov Identifier:
    NCT03074188
    Other Study ID Numbers:
    • kidney _oral findings
    First Posted:
    Mar 8, 2017
    Last Update Posted:
    Mar 8, 2017
    Last Verified:
    Mar 1, 2017
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Keywords provided by Alaa Mostafa Hassan Elnaggar, internal resident at oral medicine department, Cairo University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Mar 8, 2017